Completed PHASE4 INTERVENTIONAL 4-arm NCT01271478

Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

Effect of Telmisartan and Captopril on Systemic Inflammation of Patients on Hemodialysis

Sponsor: Coordinación de Investigación en Salud, Mexico

Conditions End-stage Renal Disease Inflammation

Interventions Placebo Telmisartan plus Captopril captopril plus placebo telmisartan plus placebo

Updated 6 times since 2017 Last updated: Dec 18, 2018 Started: Aug 31, 2009 Primary completion: Dec 31, 2010 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates End-stage Renal Disease and Inflammation and is currently completed. Coordinación de Investigación en Salud, Mexico leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Coordinación de Investigación en Salud, Mexico

Data source: Coordinación de Investigación en Salud, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico